Overview

Heart Rate Variability in Response to Metformin Challenge

Status:
Completed
Trial end date:
2016-02-01
Target enrollment:
Participant gender:
Summary
Diseases caused by brain energy supply defects can be innate (fibromyalgia secondary to familial mitochondrial disorders) or acquired (tardive dyskinesia or weight gain associated with prolonged antipsychotic use). Patients with these possible mitochondrial disorders will provide a baseline resting heart rate sample, ingest low-dose metformin (500 mg), and then provide an additional sample 2 hours later.
Phase:
Phase 2
Details
Lead Sponsor:
Woodinville Psychiatric Associates
Treatments:
Metformin